Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Diabetes in Developing Countries
Literature
1.
Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol. 1999;83:25F–9F.PubMedCrossRef
2.
Bhagat M, Mukherjee S, De P, Goswami R, Pal S, Das M, et al. Clustering of cardiometabolic risk factors in Asian Indian women: Santiniketan women study. Menopause. 2010;17:359–64.PubMedCrossRef
3.
Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Chicago: Human Kinetics Books; 1988.
4.
Ghosh A, Bhagat M. Indian diabetes risk score by menopausal status in Asian Indian Women: Santiniketan women study. J Diabetes. 2009;1:140–1.PubMedCrossRef
5.
Guha S, Pal SK, Chatterjee N, Guha S, Ghosh A, Deb PK. How predictive is the Framingham's risk prediction algorithm in Indian perspective? A retrospective case-control study from Kolkatta. Indian Heart J. 2008;60:330–2.PubMed
Metadata
Title
Comparison of Framingham Risk Score and Indian diabetes risk score by obesity status and lipids abnormality in women of Asian Indian origin: Santiniketan women study
Authors
Minakshi Bhagat
Arnab Ghosh
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
International Journal of Diabetes in Developing Countries / Issue 2/2011
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-011-0019-1

Other articles of this Issue 2/2011

International Journal of Diabetes in Developing Countries 2/2011 Go to the issue

Original Article

Difference in prevalence of diabetes, obesity, metabolic syndrome and associated cardiovascular risk factors in a rural area of Tamil Nadu and an urban area of Delhi

Review Article

Computerization of data in diabetes centers

Original Article

Frequency of prediabetes and influence of various risk factors on the development of prediabetes: a tertiary care hospital experience

Original Article

Early remission of type 2 diabetes mellitus by laparoscopic ileal transposition with sleeve gastrectomy surgery in 23–35 BMI patients

Review Article

Genetic etiology of type 2 diabetes mellitus: a review

Original Article

Islet cell autoantibodies in patients younger than 20 years of age with recently diagnosed diabetes in Northwest of Iran
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits